BioAge Labs (BIOA) Operating Income (2023 - 2026)
BioAge Labs (BIOA) posted Operating Income of -$25.4 million for Q1 2026, up 10.72% sequentially from -$28.4 million in Q4 2025, and down 54.29% YoY from -$55.5 million in Q1 2025.
BioAge Labs (BIOA) Operating Income (2023 - 2026) Analysis & Trends
BioAge Labs has reported Operating Income for 4 years, with the latest figure at -$25.4 million in Q1 2026.
- Quarterly Operating Income fell 54.29% year-over-year to -$25.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$101.7 million (down 24.3% YoY) and the FY2025 annual result came in at -$92.8 million, down 18.65% from the prior year.
- Operating Income grew to -$25.4 million in Q1 2026 per BIOA's latest filing, from -$28.4 million in the prior quarter.
- Over five years, Operating Income peaked at -$9.9 million in Q3 2023 and troughed at -$28.4 million in Q4 2025.
- A 4-year average of -$20.0 million and a median of -$23.1 million in 2025 frame the typical range for Operating Income.
- The sharpest annual moves came in 2024 and 2025: Operating Income tumbled 150.33% in 2024, then increased 6.51% in 2025.
- Over 4 years, Operating Income stood at -$13.6 million in 2023, then plunged by 86.54% to -$25.4 million in 2024, then retreated by 12.07% to -$28.4 million in 2025, then increased by 10.72% to -$25.4 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$25.4 million, -$28.4 million, and -$23.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn | -29.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.33 Mn |
| Mar 31, 2026 | -25.38 Mn |
| Dec 31, 2025 | -28.42 Mn |
| Sep 30, 2025 | -23.14 Mn |
| Jun 30, 2025 | -24.77 Mn |
| Mar 31, 2025 | -16.45 Mn |
| Dec 31, 2024 | -25.36 Mn |
| Sep 30, 2024 | -24.75 Mn |
| Jun 30, 2024 | -15.27 Mn |
| Mar 31, 2024 | -12.81 Mn |
| Dec 31, 2023 | -13.60 Mn |
| Sep 30, 2023 | -9.89 Mn |